James Hardie share price jumps on a 57% profit surge

The James Hardie Industries plc (ASX: JHX) share price is bucking the fall on the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) after it posted a big jump in FY19 profit and sales..

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The James Hardie Industries plc (ASX: JHX) share price is outperforming the market this morning after it posted a big jump in profit and sales for the full year to end March 2019.

The JHX share price jumped 1.8% to $18.15 in morning trade even as the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index shed 0.4% after yesterday's big run-up from the shock election results.

James Hardie's peers were mixed with the Boral Limited (ASX: BLD) share price slipping 0.7% to $4.88 while CSR Limited (ASX: CSR) added 0.8% to $3.60 at the time of writing.

Profit, sales and margin growth

The big jump in James Hardie's share price came after management posted a 57% increase in FY19 net operating profit to US$228.8 million ($331.3 million) on the back of a 22% increase in revenue to US$2.51 billion.

It's acquisition of Fermacell in Europe and growth in its North American Fibre Cement business contributed to the growth although US housing market demand for its products remain weak and its operating profit in the final quarter of the year fell 9% compared to the same time last year.

The good news is that conditions in the US is expected to improve in the current financial year with its chief executive Jack Truong forecasting modest growth in the US housing market in FY20.

More growth in FY20 expected

"The single family new construction market and repair and remodel market growth rates in fiscal year 2020 are expected to grow, albeit at a growth rate lower than that in fiscal year 2019. The Company expects new construction starts between approximately 1.2 million and 1.3 million," said Dr Truong.

"We expect our North America Fiber Cement segment EBIT margin to be in the top half of our range of 20% to25% for fiscal year 2020.  This expectation is based upon the Company continuing to improve operating performance in our plants, improved net average sales price and mix, continued inflation for input costs and modest underlying housing growth."

There's good news for its lagging European business as well. This division only posted an adjusted earnings before interest and tax (EBIT) margin of 10.6% if the impact from the acquisition was excluded.

However, the company said it expected to deliver year-on-year growth in sales and EBIT margin for the current financial year.

Foolish takeaway

I think the biggest takeaway from the results is the lack of unexpected bad news. While there were some cracks in the group's performance, there's nothing there to spook investors.

James Hardie and Boral had been underperforming the broader market over the past year due to a surprising slowdown in the US residential construction market. There's no V-shape recovery but at least things are slowly improving and that's enough to feel bullish about James Hardie.

But this isn't the only large cap stock worth putting on your radar. The experts at the Motley Fool have uncovered other value buys for 2019.

Follow the link below to find out what these stocks are for free.

Motley Fool contributor Brendon Lau owns shares of Boral Limited and James Hardie Industries plc. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was another woeful day for investors this Wednesday.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Cedar Woods, Humm, Star, and Zip shares are storming higher today

These shares are having a better day than most on hump day. But why?

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

Army man and woman on digital devices.
Share Gainers

Guess which ASX 300 defence stock has already rocketed 51% this week (Hint, not DroneShield)

Investors have sent this ASX 300 defence stock flying this week. But why?

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why 4DMedical, DroneShield, EOS, and Star shares are rising today

These shares are catching the eye on Tuesday. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »